User profiles for D. J. LOVELL

Lovell, DJ

Verified email at cchmc.org
Cited by 28334

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for …

…, Y Kimura, RM Laxer, DJ Lovell… - Arthritis care & …, 2011 - Wiley Online Library
Juvenile idiopathic arthritis (JIA) is defined by the International League of Associations for
Rheumatology (ILAR) as arthritis of unknown etiology that begins before the sixteenth birthday …

2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical …

…, Y Kimura, RM Laxer, DJ Lovell… - Arthritis care & …, 2013 - Wiley Online Library
The American College of Rheumatology (ACR) published treatment recommendations for
juvenile idiopathic arthritis (JIA) in 2011 (1). These recommendations represented the first …

Juvenile idiopathic arthritis

A Martini, DJ Lovell, S Albani, HI Brunner… - Nature Reviews …, 2022 - nature.com
Juvenile idiopathic arthritis (JIA) is an umbrella term for arthritis of unknown origin, lasting for
>6 weeks with onset before 16 years of age. JIA is the most common chronic inflammatory …

[HTML][HTML] Etanercept in children with polyarticular juvenile rheumatoid arthritis

DJ Lovell, EH Giannini, A Reiff… - … England Journal of …, 2000 - Mass Medical Soc
Background We evaluated the safety and efficacy of etanercept, a soluble tumor necrosis
factor receptor (p75):Fc fusion protein, in children with polyarticular juvenile rheumatoid …

Preliminary definition of improvement in juvenile arthritis

…, N Ruperto, A Ravelli, DJ Lovell… - … : Official Journal of …, 1997 - Wiley Online Library
Objective. To identify a core set of outcome variables for the assessment of children with
juvenile arthritis (JA), to use the core set to develop a definition of improvement to determine …

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal‐onset multisystem inflammatory disease (NOMID): A …

…, K Schikler, H Hoffman, DJ Lovell… - Arthritis & …, 2002 - Wiley Online Library
Objective Neonatal‐onset multisystem inflammatory disease (NOMID; also known as chronic
infantile neurologic, cutaneous, articular [CINCA] syndrome) is characterized by fever, …

2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American …

…, T Kitoh, K Lehmberg, DJ Lovell… - Arthritis & …, 2016 - Wiley Online Library
Objective To develop criteria for the classification of macrophage activation syndrome (MAS)
in patients with systemic juvenile idiopathic arthritis (JIA). Methods A multistep process, …

[HTML][HTML] Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

DJ Lovell, N Ruperto, S Goodman, A Reiff… - … England Journal of …, 2008 - Mass Medical Soc
Background Tumor necrosis factor (TNF) has a pathogenic role in juvenile rheumatoid
arthritis. We evaluated the efficacy and safety of adalimumab, a fully human monoclonal anti-TNF …

[HTML][HTML] Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

…, K Abrams, D Kim, A Martini, DJ Lovell - … England Journal of …, 2012 - Mass Medical Soc
Background Interleukin-1 is pivotal in the pathogenesis of systemic juvenile idiopathic arthritis
(JIA). We assessed the efficacy and safety of canakinumab, a selective, fully human, anti–…

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

N Ruperto, DJ Lovell, P Quartier, E Paz, N Rubio-Pérez… - The Lancet, 2008 - thelancet.com
Background Some children with juvenile idiopathic arthritis either do not respond, or are
intolerant to, treatment with disease-modifying antirheumatic drugs, including anti-tumour …